Pro-life advocates are calling for action as top federal health officials deny reports that they are delaying a promised safety review of the abortion pill.
Pro-life advocates are calling for action as top federal health officials deny reports that they are delaying a promised safety review of the abortion pill.
The Food and Drug Administration (FDA), an agency of the U.S. Department of Health and Human Services, “has delayed a promised review of safety data” until after midterm elections at Commissioner Marty Makary’s request, a Tuesday report by Bloomberg Law claimed, citing unnamed sources.
The U.S. Department of Health and Human Services (HHS) has denied the claim, saying it is “baseless.”
“Assertions that the FDA is slow walking this review for political purposes are baseless,” an HHS spokesperson told CNA.
“FDA takes the time necessary to conduct comprehensive scientific reviews, and that is what Dr. Makary is ensuring as part of the Department’s commitment to gold-standard science and evidence-based reviews,” the statement continued.
In response, Republican Sen. Josh Hawley of Missouri — an outspoken advocate for reviewing abortion pill safety regulations — called the FDA’s actions “unacceptable.”
In a letter addressed to Makary, Hawley urged the FDA
